Mark E. Dmytruk - Chief Financial Officer at Ginkgo Bioworks Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
DNA, DNA-WT on NYSE, DNABW on OTC
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Mark E. Dmytruk - trading volume in the past year for Ginkgo Bioworks Holdings, Inc.

Holdings reported by Mark E. Dmytruk for Ginkgo Bioworks Holdings, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 28.7K $8.25K $0.29 Sep 12, 2024 Direct
Restricted Stock Units 24.1K $6.91K $0.29 Sep 11, 2024 Direct Class A Common Stock
Class B Common Stock 15.5K $4.45K $0.29 Sep 11, 2024 Direct Class A Common Stock

Transactions reported by Mark E. Dmytruk for Ginkgo Bioworks Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.